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Introduction—Cancer registration is an important activity for informing cancer control 
activities. Cancer registries in Sub-Saharan Africa have limited resources to effectively operate 
because of competing priorities. To date, there has not been an assessment of the resources and 
funding needed to perform all the activities essential for cancer registration in Kenya. Evidence 
will help registries to quantify and advocate for the funds needed to sustain, enhance, and expand 
high quality cancer registration in Kenya.
Methods—In this study, we used the Centers for Disease Control and Prevention’s (CDC’s) 
International Registry Costing Tool (IntRegCosting Tool) to evaluate the funding, cost, and labor 
resources used to perform the cancer registry operations in Nairobi County for two annual periods 
between July 2012 and June 2014.
Results—Funding from grants, research studies, and international organizations provided 70% of 
the registry operations’ cost. For both time periods, the most-costly registry activities were related 
to administration, management, and training, along with data acquisition activities such as data 
abstraction, entry, and validation. Even among these core registry activities, however, substantial 
variations existed.
Conclusions—Stable funding for cancer registry operations is necessary to sustain core registry 
activities in other to deliver high-quality data, which in turn is necessary to foster evidence-based 
policies to improve cancer outcomes. As stakeholders look into expanding the Nairobi Cancer 
Registry into a national program, the cost data provided in this study will help justify the funding 
required for sustaining and expanding registry activities.
Keywords
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1. Introduction
In Kenya, cancer is ranked third as a cause of death, after infectious and cardiovascular 
diseases, accounting for approximately 7% of the total national mortality [1]. Although 
national data about cancer are not available, GLOBOCAN estimates that approximately 
41,000 new cases of cancer occurred in Kenya in 2012, with 28,453 deaths [2]. The overall 
cancer incidence rate was 167.2 per 100,000 for men and 196.6 per 100,000 for women [2]. 
In low and middle income countries (LMIC), the problem of rising cancer rates is 
compounded by poor prevention, lack of early detection, and health care facilities that could 
lead to early treatment interventions.
Timely dissemination of cancer surveillance data to the policy makers and scientists 
responsible for designing, implementing, and evaluating cancer prevention and control 
activities is vital [3]. Population-based cancer registries collect information on cancers in a 
defined population; these data are needed to calculate cancer incidence, mortality, 
prevalence, and survival trends, show distribution of stage at diagnosis and treatments 
received, help inform and evaluate cancer prevention, control and treatment efforts, and to 
generate hypotheses for further research.
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Despite the importance of cancer registration for producing data needed to inform decisions 
about cancer control activities, obtaining the resources required to operate and sustain 
quality registries remains a major challenge in Sub-Saharan Africa, where health priorities 
compete for limited resources. These challenges are compounded by a lack of information 
about the resources required to effectively run all the activities essential for cancer 
registration. Without such evidence, it is difficult to advocate for the funding needed to 
sustain high quality cancer registration in Kenya.
Kenya is an East African country bordered by the Indian Ocean, Somali, Uganda, Rwanda 
and Ethiopia. It has three main population-based cancer registries, located in Nairobi, 
Eldoret, and Kisumu (Fig. 1). These registries are described in Table 1. The Nairobi Cancer 
Registry was established after consultations between the United States National Cancer 
Institute (US NCI), the International Agency for Research on Cancer (IARC), the Kenya 
Ministry of Health, and KEMRI. The establishment of the registry was approved by the 
Scientific Steering Committee and the Ethics Research Committee of KEMRI and endorsed 
by the Kenya Ministry of Health and the World Health Organization. The registry has 
maintained its role as a recognized key player in cancer registration in Africa. By fostering 
relationships with both local and international cancer control stakeholders, the registry has 
mobilized resources to maintain its operation. The registry offers technical support to newly 
established hospital-based and population-based registries in Kenya and facilitates trainings 
for cancer registries in other parts of Africa in collaboration with the Africa Cancer Registry 
Network (AFCRN).
The Eldoret Cancer Registry is a population-based cancer registry that operates within the 
Hemato-Oncology department of Moi University and is located in the same complex as the 
Moi Teaching and Referral Hospital; it’s main source of data. Some of the registry’s staff 
members (such as the Director and the Secretary) are employees of Moi University, and 
others are volunteers who serve for short time periods. Moi University students occasionally 
help (as volunteers or are given a small stipend) with data collection from hospitals, 
pathology laboratories, and registries of vital statistics.
The Kisumu Cancer Registry, which is a population-based cancer registry located within the 
Kisian Campus of KEMRI in Kisumu, captures unique, well-documented data on HIV-
related malignancies; Kaposi Sarcorma and Non-Hodgkins Lymphoma, in addition to the 
standard cancer registry data.
The aims of this study were to 1. Determine the economic costs of running a cancer registry 
in Kenya, 2. Understand the factors that affect the collection of high-quality data, and 3. 
Quantify the costs associated with each activity performed by the registry. The Nairobi 
Cancer Registry was selected as the main site for the economic evaluation of cancer 
registration in Kenya, as it is the largest registry and serves as a focal point for increasing 
cancer registration across the country.
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2. Materials and methods
2.1. Nairobi Cancer Registry coverage area
Nairobi is 1 of 47 counties in Kenya and hosts the country’s capital city (Fig. 1). It is in the 
South Central region of the country. The registry covers approximately 696 square 
kilometers, which is about 0.3% of the total area. It is an urban area with residents from both 
high and low socioeconomic classes. Nairobi has sizeable populations of Asians, Europeans, 
and Somalis, making it uniquely representative of Kenya’s diverse ethnic groups. The city of 
Nairobi enjoys the status of a full administrative county. There are eight main administrative 
divisions (Central, Dagoretti, Embakasi, Kasarani, Kibera, Makadara, Pumwani, and 
Westlands). The population of Nairobi County was 3,138,639 according to the 2009 
National Census [4]. Nairobi County is the largest populated county in Kenya, at about 8.1% 
of the total country population. The United States Central Intelligence Agency (CIA) 
estimates that the population of Kenya in 2015 was 45,925,301 with an annual growth rate 
of 1.93% [5].
2.2. Registry data collection approach and review of data quality
The registry reports data on all residents of Nairobi, defined as anyone who has lived in 
Nairobi for at least a 6-month period. Cancer registrars are recruited, trained, and deployed 
to collect data from the different sources used by the registry. The registry uses an active 
method of case finding and abstraction. This approach is a systematic process by which 
cancer cases eligible for registration or inclusion in the database are identified. Using an 
active method approach, employees or volunteers visit the various sources to identify and 
abstract the relevant information.
In the beginning, the registry collected information on residents and all people referred from 
other parts of the country for cancer treatment in Nairobi. The amount of data processed was 
much higher than the incident cases reported, and the workload was substantial. Based on 
this experience, the data collection process was changed and the registry concentrated on 
finding only the Nairobi resident cases in the more than twenty facilities that the registry 
covers.
The data items collected are relatively standard. They include the following:
1. Patient details: First name, given/maiden name, last name (surname), ID number, 
age/date of birth, gender, concurrent illness, current residence, place (district) of 
birth, religion, and tribe/ethnicity.
2. Tumor: Incidence date, basis of diagnosis, primary site/topography (ICD-O-3) 
code, histology/morphology (ICD-O) code, behavior, grade, and stage at 
diagnosis.
3. Treatment(s): Initial and subsequent treatment modalities: surgery, radiation, 
chemotherapy and hormonal, and date(s) of treatment
4. Sources of data: Hospital or laboratory name, hospital number, laboratory report 
number, and date of abstraction.
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5. Follow-up: Patient status (alive or dead) at date of incidence; last date of contact 
with physician/health-care provider or, if dead, date and cause of death; hospice 
number.
6. Concurrent illness: any concurrent illness is recorded including documentation of 
HIV status, which began as a pilot study (funded research project). Findings 
from the pilot study [6] showed that the registry required minimal resources (if 
any) to collect these additional data hence the registry continued to document 
HIV as one of its variables.
The process of data collection has been previously described [7]. Government and private 
hospitals, hospices, hematology and histopathology laboratories, and cancer centers are 
sources of data. Other sources are comprehensive care centers, outpatient clinics, imaging 
units, and medical wards. In the hospitals, data were abstracted mainly from medical records 
departments and radio-therapy units. Pre-designed case registration forms were used to 
capture data from medical records. Death certificates mentioning cancer were identified in 
the civil registration of births and deaths and abstracted onto the registration forms. Further 
checks were subjected to cases abstracted in the civil registrar’s office because of known 
inaccuracies on death certificates. Death certificates were traced back to the clinical records 
to verify the information. The death certificate notified cases were matched against the 
registry database, and for cases already registered, status at last contact was updated and the 
cause of death included. The specific approach used to identify and abstract data from each 
source is described below:
i. Government and Private Hospitals—Registrars collect data from 26 major 
hospitals. They use disease index cards and patient-care service registers to 
identify cancer cases in both inpatient and outpatient departments. A few 
hospitals have established computer-based disease indices that are also used to 
identify cancer cases.
ii. Medical Laboratories—Many of the government and private hospitals have 
specialty laboratories that include histology, hematology, and cytology. Registry 
staff visit and collect data from 10 laboratories.
iii. Radiotherapy Treatment Centres—The radiotherapy units at Kenyatta National 
Hospital and Nairobi Hospital provide care for newly diagnosed or recurrence 
cancer patients who visit these facilities for radiotherapy services.
iv. The Nairobi Hospice—Most of the data from the Nairobi Hospice is on patients 
referred from Kenyatta National Hospital and the other health care facilities in 
Nairobi. Cancer registrars visit the hospice to collect up-to-date information on 
patients’ status, which is used for follow-up and case assessment.
v. Vital Statistics Registrar of Births & Deaths (Death Certificates Office)—In 
2006, the registry established a link with vital statistics to access cancer-specific 
mortality data.
Coding of tumor site (topography) and histology (morphology) is done according to 
International Classification of Diseases for Oncology (ICD-O 3) [8]. The CanReg5 software 
[9], an open-source tool developed by the IARC designed to input, store, check and analyze 
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cancer registry data, automatically converts the pairs of topography/morphology codes to the 
appropriate code in the 10th revision of the International Classification of Diseases (ICD-10) 
[10]. Multiple primary cancers are defined according to the 2004 IARC rules. Similarly, the 
registry adheres to IARC guidelines on confidentiality in connection with or during the 
collection, storage, use, and transmission of identifiable data.
Data management are performed using CanReg5 software [9], which checks for duplicate 
registrations (as well as the validity and consistency of coded data). Case registration forms 
that lack sufficient information were put aside for further re-abstraction. Studies on 
completeness have not been carried out in this registry. However, the registry does review 
the percentage of morphologically verified cases (MV); uses death certificate clearance to 
identify Death Certificated Only (DCO) cases; and when data for the same case is obtained 
from many sources such as: hospitals, the hospice, private clinics and laboratories – allowing 
for cross verification, these cases may have a higher quality index – all of these procedures 
are part of the internal quality evaluation process. Though the Nairobi Cancer Registry data 
did not meet the high-quality standards required for inclusion in Cancer Incidence in Five 
Continents (CI5) volume 10 released in 2014; the data is still being used to give policy 
makers an idea of the cancer burden in Kenya.
2.3. Cost data collection approach
The Nairobi Cancer Registry was the first low and middle income country registry selected 
to pilot test the Centers for Disease Control and Prevention’s (CDC’s) International Registry 
Costing Tool (IntRegCosting Tool) which was based on Excel software with plans to 
subsequently have a web based tool. A catalogue of registry activities and their definitions 
was developed in consultation with the registry director and supervisor. The IntRegCosting 
Tool consists of 10 components [11] that were finalized with input from registry staff. 
Information on labor and non-labor resources were provided for each component and 
assigned to specific activities. Two rounds of cost data were collected for 2 consecutive 
fiscal years: July 2012 through June 2013, and July 2013 through June 2014.
3. Calculations
3.1. Reporting of incident cases
We generated numbers of cases registered with incidence dates from January 2012 through 
December 2013 from the CanReg5 database. We excluded cases registered during the period 
that had an incidence date outside the 2 years. These estimates would serve as the 
denominator to calculate the cost per case.
To provide details on overall cancer incidence, we report the top 6 most common cancers for 
males and females separately using age specific rates per 100,000 for the time period from 
2007 to 2011. We also report age-standardized incidence rates for the time period from 2004 
to 2008. Age standardization was carried out by the direct method using the “world standard 
population” [12] to obtain the World age-standardized rate (ASR) per 100,000 populations. 
We used the 2009 census to generate the population estimates.
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3.2. Cost and resource use
We analyzed the cost data using Microsoft Excel. We identified all sources of funding for 
the cancer registry and cataloged the resources associated with these sources. Most of the 
sources provided funds directly, which we were able to identify and allocate accurately. The 
host institution, KEMRI, contributed both through direct transfers (generally salary for 
selected staff) and through other contributions, such as use of facilities and other 
administrative processes and equipment (IT support, computers, and printers). The host 
institution direct transfer payments could be accurately captured, but other in-kind 
contributions could only be quantified through “best-case estimation.”
We allocated labor and non-labor information from the Microsoft Excel–based 
IntRegCosting Tool to specific registry activities. For each registry personnel, we had 
information on their salary and proportion of time spent on each type of registry activity, 
which allowed us to allocate cost as well as calculation of full-time equivalents (FTEs). We 
defined an FTE as a registry staff person who was employed full time and worked 40 h per 
week. We showed the distribution of the registry’s resources by source for round 1 and 
round 2 data and including in-kind contributions. We estimated the cost by specific cancer 
registry activities by round, and assessed the number of registry staff FTEs devoted to each 
type of registry activity, based on the labor amounts reported in the tool.
The sources of funding to support the Nairobi Cancer Registry operations tend to vary from 
year to year, and therefore, we collected sources of funding and cost of operations over a 2-
year time period. We present the sources of data combined across the 2 years and show 
activities and FTEs by year to identify variation in the resources expended on operations
4. Results
The Nairobi Cancer Registry records approximately 1870 incident cases for any given year 
of diagnosis. These data reflect the incidence per year, not the number potentially abstracted 
and processed. The number of cases collected varies year to year depending on the resources 
available for cancer registration. Furthermore, case registration forms missing key 
information, such as date of diagnosis, are set aside without being entered into the registry 
database and are returned to the registrars for re-abstraction and validation. As indicated 
earlier, the Nairobi Cancer Registry does not have a continuous source of funding. In times 
of limited funding, case abstraction and processing slows causing a back log followed by an 
eventual catch-up with increased registrations when funds become available. For example, 
the registry processed 8381 cases during annual period 2012–2013, and 2000 cases in 2013–
2014.
There were several factors observed that would affect the collection of high quality data. 
These include access of registry staff to data source filing areas, storage of data and filing 
procedures at data sources; documentation of patient and disease information by healthcare 
workers at provider sites; and staff availability compared to the number of data sources/work 
load. Additional challenges are also relate to retaining trained staff as inadequate 
compensation results in high turnover.
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Despite the challenge of discontinuous funding, the Nairobi Cancer Registry has been able 
to produce cancer incidence data since the year 2000 to inform the planning of cancer 
prevention and control activities in Kenya. Fig. 2 presents the crude age-specific incidence 
rates per 100,000 population for the period 2007–2011 for both males and females. As 
expected, older age groups have higher incidence rates than younger individuals but there 
are differences between males and females. Cancers experienced by men (especially prostate 
cancer) have an increasing incidence as one ages while cancers diagnosed among women 
(specifically breast and cervical) peak at about age 40 to 50 years and then decline. Prostate 
cancer was the top cancer in men with an age-standardized incidence rate of 40.6 per 
100,000 (not shown in figure). Breast cancer was the most common cancer among women 
followed by cervical cancer. Breast cancer has an age-standardized incidence rate of 51.7 per 
100,000 and cervical cancer has an age-standardized incidence rate of 46.1 per 100,000 [7].
Fig. 3a and b provides the sources of funding for the registry over each period, from July 
2012 through June 2013 and July 2013 through June 2014. Funding from grants; research 
studies; and international organizations, including the IARC, AFCRN, and International 
Network for Cancer Treatment and Research (INCTR), accounted for about 70% of the 
registry operations’ cost. The other approximately 30% was supported by host institution 
contributions from KEMRI. AFCRN is partly funded by CDC, through a grant to support 
cancer registration, via the IARC. Specific grants and research studies varied between the 
years, although altogether they made up about 33% of the funding in both rounds. The IARC 
contribution increased from 3% in the first annual period to 27% of the total in the second 
annual period. Funding is received for general cancer registry operations as well as specific 
studies and therefore the type of activities that the registry staff perform at specific times 
will vary. Appendix A Table A1 presents the detailed funding amounts by source.
Fig. 4 presents the distribution of registry resources by budget category as an average of total 
resources from July 2012 through June 2014. Labor used the largest amount of resources, 
with 56%, while computers, travel, training, and other materials used 30% of the registry 
resources. Indirect, administrative, and software used 9% of the registry resources while 
consultants used the smallest amount of resources, 5%
Fig. 5 presents the distribution of cost and FTEs by registry activities for two annual periods. 
In both time periods, the most costly registry activities were related to registry 
administration, management, and training along with data acquisition activities such as data 
abstraction, entry, and validation. The years substantially differed in terms of the data 
collection and management activities, likely reflecting the prioritization of resources during 
the annual period. Training costs also showed large variation between the two years; this 
includes training received by staff both locally and outside the country. Travel costs 
associated with training are likely the reason for the difference between the years, as there is 
not much difference in FTEs or staff time, as shown in Fig. 5b. Other activities with 
significant differences in labor hours between the years included data abstraction and data 
entry. For example, in the first year, 2.5 FTEs performed data entry, whereas in the second 
year, only about 0.5 FTEs were used. Similarly, data abstraction differed by about 1.5 FTE 
between the 2 years.
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5. Discussion
Over the 2-year period between July 2012 and June 2014, more than two-thirds of the 
funding for the Nairobi Cancer Registry came from research grants, the IARC, and AFCRN. 
Support from KEMRI, the host institution, covered only about a third of the total registry 
expenditure. Although grants for specific research studies were an important source of 
funding for cancer registration, more stable sources of funding are necessary to ensure 
adequate funds are consistently available across years. To develop quality registries, 
sustained investment in infrastructure is needed.
Cost expended on registry activities varied substantially between the 2 years on the basis of 
the availability of funding to support specific registration activities. A 2014 study reported 
approximately US $ 8–9 in direct funding per case registered for countries in sub-Saharan 
Africa [13]. The registry has numerous data sources that need to be visited on a regular 
basis, and data collection activities vary by source and requires staff expertise to work with a 
variety of sources and inputs. The Nairobi registry has faced numerous challenges over the 
past few years, especially limited funding, which has hindered their ability to hire full-time 
staff to maintain consistency in registry operations. The registry has engaged volunteers on 
short-term assignments or contracted staff when funding is available. Therefore, there is high 
staff turnover. The registry routinely loses much of its experienced staff and needs to 
constantly train new staff, which increases the resources required for training. In 2012–2013, 
funding was not sufficient to compensate contracted staff to collect data at the reporting 
sites. This resulted in delays in data collection and increased the time taken to report 
complete data. However, with a prevailing focus on data entry, resources for data entry 
increased hence the high number of registrations. The significant variations in FTEs by 
activity may also be because different research grants have different requirements. This 
study shows the importance of analyzing both overall cost and labor resources to obtain a 
more-comprehensive assessment of registry operations. Institutional and external support 
that can offer stable funding for cancer registration is needed to operate high-quality 
registries in Kenya. Grants, although an unstable source of funding, require the cancer 
registry to perform core registry activities to achieve results or fulfill the deliverable, which 
goes towards benefitting the overall operations of the registry, albeit disproportionately. For 
example, follow up studies to determine survival of cancer patients from one or a group of 
cancers, requires registry staff to conduct case finding and abstraction (core activities of the 
registry) to identify patients that need to be followed up to ascertain their status.
A quality and needs assessment was undertaken in April 2015 in the existing registries in 
Kenya with support from the US NCI. This entailed evaluating the performance and needs of 
each of the three registries (Nairobi, Eldoret, Kisumu) and determining the steps needed to 
broaden data capture and improve quality. The needs assessment highlighted the limited 
number of staffing in the three registries. The US NCI committed to support the three 
registries for a five-year period in a phased-funding approach with the host institutions being 
urged to commit additional resources for continuity of the registries. Adequate compensation 
for personnel is essential for continuity and sustainability of registry operations.
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Given the strategic location of the Nairobi Cancer Registry—which is based in the capital, 
along with Kenya’s major cancer treatment centers, oncologists, and the headquarters of 
KEMRI—stakeholders have proposed that the Nairobi Cancer Registry be scaled up to a 
National Cancer Registry Program that will collect and report data from population-based 
cancer registries in Kenya. The National Cancer Registry Program was launched in February 
2016 and the government of Kenya has provided seed funds to start up the program. It is 
anticipated that local and international partners will join in supporting the program. The 
establishment of the National Cancer Registry Program was necessitated by demand from 
the county governments interested in developing registries to understand the burden of 
cancer in their counties. In addition, the cancer registry track during a stakeholders meeting 
held in 2014 noted that there was need to increase the coverage of cancer registration in 
Kenya by strengthening the existing registries, expanding to other regions of Kenya and 
merging the data in a centralized database. As a national body responsible for carrying out 
health research in Kenya and the experience of maintaining a population-based registry, 
KEMRI was proposed as the host of the registry and will collaborate with the Kenya 
Ministry of Health and National Cancer Institute of Kenya to oversee all cancer-related 
activities in the country. The national registry program will be responsible for ensuring use 
of standardized data collection tools and developing and implementing a cancer registry 
awareness program targeting hospital staff (chief executive officers, medical 
superintendents, oncologists, pathologists, clinicians) with a goal of improving 
documentation of medical information so that data quality improves. The national registry 
program will also support the establishment of additional registries in Kenya by providing 
technical support, training of staff, data collection from all population-based registries, and 
reports on cancer burden that will be used for further research and to inform cancer 
prevention, management and control. The costing analysis presented in this study served as a 
valuable resource for understanding the economics of operating cancer registries, provided 
guidance for approaches to integrate and expand the activities of the existing registries in an 
efficient manner, and serves as a baseline to assess progress. For example, the economic 
evaluation has spearheaded much-needed discussion on which registry tasks need to be 
centralized versus decentralized to create an efficient network of national registration in 
Kenya.
Although we have made substantial effort to obtain accurate cost and resource use data, 
several limitations need to be highlighted. First, the two annual periods of data analyzed 
showed large variation. Therefore, many more years of data may be required to see 
consistent patterns in the cost of specific activities and the cost per case. Second, the 
distribution of resources under stable and adequate funding for registry activities may result 
in a different distribution of resources to registry activities. We hope to be able to study this 
in the future when the National Cancer Registry Program is fully established in Kenya. 
Third, although we have assessed factors internal to the registry that are likely to affect the 
cost of operations, we did not systematically assessed external factors. For example, the 
number of reporting facilities and quality of data maintained at these facilities was not 
assessed. Furthermore, even though cancer is a reportable disease in Kenya, compliance with 
reporting is low, which poses additional challenges. These external factors and their impact 
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on cost and data quality need to be studied in detail to inform the optimal approaches as 
cancer registration is scaled up in Kenya.
6. Conclusions
Information collected by cancer registries is valuable to researchers, policy makers, and 
public health officials for purposes of planning and evaluating cancer control programs and 
interventions along the continuum of care from prevention, to screening, to diagnosis, and to 
treatment. The data generated from cancer registries also provide an essential platform 
where additional in-depth research analysis can be launched. Therefore, cancer registration 
is an essential activity that needs adequate support to ensure accurate and complete data.
The economic study of the Nairobi Cancer Registry has provided valuable information on 
resources needed to run a cancer registry and has highlighted the variation in resources 
expended on registration activities across the two annual periods studied. The cancer registry 
does not have continuous funding to maintain registry operations, and therefore, it must rely 
on research funding and other contributions that may be available only for a given time 
period. The inconsistent registry funding results in discontinuity of registration activities and 
high staff turnover, which impacts both training costs and quality of the data. Stable funding 
for cancer registry operations in Kenya is therefore essential to deliver the high-quality data 
necessary to implement evidence-based policies to improve cancer outcomes. As 
stakeholders look into expanding the Nairobi Cancer Registry into a national program, the 
cost data provided in this study will be useful in justifying the funding required for 
sustaining and expanding registry activities.
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Appendix A
Table A1
Nairobi Cancer Registry Total Resources by Source, U.S. Dollars.
July 2012–June 2013 July 2013–June 2014
Kenya Medical Research Institute (KEMRI) 26,317 30,388
African Registry Network (AFCRN) 26,281 12,414
International Agency for Research on Cancer (IARC) 2667 28,448
Grants/Other Research Studies 27,440 35,779
Total Funding 82,705 107,029
Note: 1 U.S. Dollar = 87 Kenyan Shillings in 2014.
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Fig. 1. 
Map of Kenya showing the location of the Nairobi, Kisumu, and Eldoret Cancer Registries.
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Fig. 2. 
Nairobi county age-specific incidence rates per 100,000 population, 2007–2011.
a. Males
Note: Mouth includes oral cavity and pharynx
b. Females
Note: Mouth includes oral cancer and pharynx
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Fig. 3. 
Nairobi Cancer Registry Distribution of Total Resources by Source.
a. July 2012–June 2013
Note: Kenya Medical Research Institute (KEMRI) operates as the host institution for the 
Nairobi Cancer Registry. AFCRN is partly funded by CDC, through a grant to support 
cancer registration, via the IARC.
b. July 2013–June 2014
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Note: Kenya Medical Research Institute (KEMRI) operates as the host institution for the 
Nairobi Cancer Registry. AFCRN is partly funded by CDC, through a grant to support 
cancer registration, via the IARC.
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Fig. 4. 
Nairobi Cancer Registry Resources by Budget Category, July 2012–June 2014.
Note: We show the average cost results using data collected for July 2012–June 2014.
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Fig. 5. 
(a) Nairobi Cancer Registry Costs by Activity (Kenyan Shillings) for the two rounds of data 
collection. (b) Nairobi Cancer Registry Full-time equivalents (FTEs) by Activity for the two 
rounds of data collection.
Note: 1 U.S. Dollar = 87 Kenyan Shillings in 2014.
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Table 1
Description of three population based cancer registries in Kenya.
Name of the Cancer 
Registry
Year of Establishment Location Geographical Coverage Population 
Covered 
(2009 Census)
Nairobi Cancer Registry 2001 Kenya Medical Research 
Institute (Centre of Clinical 
Research)—Nairobi
Nairobi County—696 square 
kilometres
3,138,639
Eldoret Cancer Registry 1998 Moi University (Department 
of Haematology & Blood 
Transfusion)—Eldoret
Uasin Gishu County— 3345.2 
square kilometres
894,179
Kisumu Cancer Registry 2010 Kenya Medical Research 
Institute (Centre for Global 
Health Research)—Kisumu
Kisumu County—2085.9 square 
kilometres
968,909
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